Merck & Co., Inc. (MRK)

NYSE: MRK · IEX Real-Time Price · USD
131.95
+0.20 (0.15%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Total Valuation

Merck & Co. has a market cap or net worth of $333.68 billion. The enterprise value is $361.64 billion.

Market Cap 333.68B
Enterprise Value 361.64B

Important Dates

The next confirmed earnings date is Thursday, April 25, 2024, before market open.

Earnings Date Apr 25, 2024
Ex-Dividend Date Mar 14, 2024

Share Statistics

Merck & Co. has 2.53 billion shares outstanding. The number of shares has increased by 0.20% in one year.

Shares Outstanding 2.53B
Shares Change (YoY) +0.20%
Shares Change (QoQ) -0.20%
Owned by Insiders (%) 0.07%
Owned by Institutions (%) 78.61%
Float 2.53B

Valuation Ratios

The trailing PE ratio is 942.50 and the forward PE ratio is 15.25. Merck & Co.'s PEG ratio is 0.11.

PE Ratio 942.50
Forward PE 15.25
PS Ratio 5.55
Forward PS 5.19
PB Ratio 8.88
P/FCF Ratio 36.50
PEG Ratio 0.11
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.45, with an EV/FCF ratio of 39.55.

EV / Earnings 990.79
EV / Sales 6.02
EV / EBITDA 52.45
EV / EBIT 119.63
EV / FCF 39.55

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.93.

Current Ratio 1.25
Quick Ratio 0.68
Debt / Equity 0.93
Debt / EBITDA 5.08
Debt / FCF 3.83
Interest Coverage 2.64

Financial Efficiency

Return on equity (ROE) is 0.90% and return on invested capital (ROIC) is 0.63%.

Return on Equity (ROE) 0.90%
Return on Assets (ROA) 0.30%
Return on Capital (ROIC) 0.63%
Revenue Per Employee $834,931
Profits Per Employee $5,069
Employee Count 72,000
Asset Turnover 0.57
Inventory Turnover 2.63

Taxes

In the past 12 months, Merck & Co. has paid $1.51 billion in taxes.

Income Tax 1.51B
Effective Tax Rate 80.55%

Stock Price Statistics

The stock price has increased by +25.04% in the last 52 weeks. The beta is 0.38, so Merck & Co.'s price volatility has been lower than the market average.

Beta (1Y) 0.38
52-Week Price Change +25.04%
50-Day Moving Average 124.56
200-Day Moving Average 111.52
Relative Strength Index (RSI) 74.96
Average Volume (30 Days) 8,735,054

Short Selling Information

The latest short interest is 23.16 million, so 0.91% of the outstanding shares have been sold short.

Short Interest 23.16M
Short Previous Month 16.82M
Short % of Shares Out 0.91%
Short % of Float 0.92%
Short Ratio (days to cover) 2.41

Income Statement

In the last 12 months, Merck & Co. had revenue of $60.12 billion and earned $365.00 million in profits. Earnings per share was $0.14.

Revenue 60.12B
Gross Profit 43.99B
Operating Income 2.36B
Pretax Income 1.88B
Net Income 365.00M
EBITDA 6.90B
EBIT 3.02B
Earnings Per Share (EPS) $0.14
Full Income Statement

Balance Sheet

The company has $7.09 billion in cash and $35.06 billion in debt, giving a net cash position of -$27.96 billion or -$11.04 per share.

Cash & Cash Equivalents 7.09B
Total Debt 35.06B
Net Cash -27.96B
Net Cash Per Share -$11.04
Equity / Book Value 37.58B
Book Value Per Share 14.84
Working Capital 6.47B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $13.01 billion and capital expenditures -$3.86 billion, giving a free cash flow of $9.14 billion.

Operating Cash Flow 13.01B
Capital Expenditures -3.86B
Free Cash Flow 9.14B
FCF Per Share $3.60
Full Cash Flow Statement

Margins

Gross margin is 73.17%, with operating and profit margins of 3.92% and 0.61%.

Gross Margin 73.17%
Operating Margin 3.92%
Pretax Margin 3.12%
Profit Margin 0.61%
EBITDA Margin 11.47%
EBIT Margin 5.03%
FCF Margin 15.21%

Dividends & Yields

This stock pays an annual dividend of $3.08, which amounts to a dividend yield of 2.33%.

Dividend Per Share $3.08
Dividend Yield 2.33%
Dividend Growth (YoY) 5.63%
Years of Dividend Growth 14
Payout Ratio 2,200.00%
Buyback Yield -0.20%
Shareholder Yield 2.14%
Earnings Yield 0.11%
FCF Yield 2.74%
Dividend Details

Analyst Forecast

The average price target for Merck & Co. is $129.67, which is -1.73% lower than the current price. The consensus rating is "Buy".

Price Target $129.67
Price Target Difference -1.73%
Analyst Consensus Buy
Analyst Count 15
Revenue Growth Forecast (5Y) 4.62%
EPS Growth Forecast (5Y) 142.20%
Stock Forecasts

Stock Splits

The last stock split was on June 3, 2021. It was a forward split with a ratio of 1048:1000.

Last Split Date Jun 3, 2021
Split Type Forward
Split Ratio 1048:1000

Scores

Merck & Co. has an Altman Z-Score of 4.34 and a Piotroski F-Score of 6.

Altman Z-Score 4.34
Piotroski F-Score 6